Chemotherapy can potentially contribute to the development of myelofibrosis, particularly as a late effect following treatment for certain cancers. It may cause damage to the bone marrow, leading to abnormal scar tissue formation and impaired blood cell production. However, myelofibrosis can also arise from other causes, including genetic mutations and underlying diseases. If you have concerns about chemotherapy and myelofibrosis, it’s important to discuss them with a healthcare professional.
Idiopathic myelofibrosis typically becomes progressively worse and can cause death
does myleofrobsis affect memory & why
It can cause bone pain, especially in the legs
Although historically there has not been much improvement in the treatment of myelofibrosis, that has changed recently. The main treatment now consists of taking a medication known as "Jakafi" which targets the gene thought to cause myelofibrosis.
Myelofibrosis can progress to acute lymphocytic leukemia or lymphoma
Yes, myelofibrosis can cause leg cramps, although they are not a direct symptom of the condition itself. Myelofibrosis can lead to anemia and other complications that may contribute to muscle cramps. Additionally, factors such as reduced blood flow or imbalances in electrolytes due to the disease or its treatment can also play a role. If you are experiencing leg cramps, it's important to discuss this with your healthcare provider for appropriate evaluation and management.
Myelofibrosis goes by many names including idiopathic myelofibrosis, agnogenic myeloid metaplasia, chronic myelosclerosis, aleukemic megakaryocytic myelosis, and leukoerythroblastosis
Not all forms of chemotherapy can cause hair loss. Many have the potential for hair loss, but it is not a guaranteed side effect. For example, there are two kinds of chemotherapy, Aromasin and Tamoxifan. they are both pill form of chemotherapy and do not normally cause hair loss.
Myelofibrosis is caused by an abnormality in a single stem cell, which causes it to grow out of control
About one quarter of all patients with myelofibrosis have no symptoms (asymptomatic)
Chemotherapy can lead to stomatitis and increase the risk of tooth decay.
Yes